Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $1.1 million.

  • CervoMed's Net Cash Flow rose 14928.99% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year increase of 9410.31%. This contributed to the annual value of $1.2 million for FY2024, which is 6738.14% down from last year.
  • As of Q3 2025, CervoMed's Net Cash Flow stood at $1.1 million, which was up 14928.99% from -$6.8 million recorded in Q2 2025.
  • CervoMed's 5-year Net Cash Flow high stood at $10.2 million for Q3 2022, and its period low was -$42.8 million during Q2 2024.
  • For the 4-year period, CervoMed's Net Cash Flow averaged around -$4.0 million, with its median value being -$1.4 million (2024).
  • Per our database at Business Quant, CervoMed's Net Cash Flow plummeted by 27316.74% in 2024 and then surged by 20551.7% in 2025.
  • Quarter analysis of 4 years shows CervoMed's Net Cash Flow stood at $6.3 million in 2022, then tumbled by 141.73% to -$2.6 million in 2023, then soared by 147.72% to $1.3 million in 2024, then decreased by 11.08% to $1.1 million in 2025.
  • Its Net Cash Flow stands at $1.1 million for Q3 2025, versus -$6.8 million for Q2 2025 and $1.5 million for Q1 2025.